Search

everythinglearnresearchcommunity

for

Search:↓

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib treatment is used for teenagers with alopecia areata.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib is effective and safe for treating severe alopecia areata.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.